Vistagen Therapeutics Overview
Vistagen Therapeutics Discounted Cash Flow
DCF Analysis for VTGN.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.13
Current Fair Value
$2.13
↑ 269.4% Upside
Undervalued by 269.4% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison